文献速递妇科生殖医学

输卵管切除术与输精管切除术用于永久避孕的成本效果比较

Cost Effectiveness of Salpingectomy Compared With Vasectomy for Permanent Contraception.
PubMed 文献 · Obstet Gynecol · 2025-08-28

本研究采用决策树模型,对假定80万人的队列比较输精管切除术与输卵管切除术用于永久避孕的成本效果。结果显示,在每获得或损失一个质量调整生命年(QALY)支付意愿阈值10万美元下,输卵管切除术的增量成本效果比为每QALY 143,769美元,不具有成本效果;但每年可减少1,215例意外妊娠、6,085例卵巢癌病例和4,921例卵巢癌死亡。作者认为共享决策时应讨论输卵管切除术的长期健康获益。

要点

  • 在10万美元/QALY支付意愿阈值下,输卵管切除术相对输精管切除术的ICER为143,769美元/QALY,不具有成本效果。
  • 概率敏感性分析显示输精管切除术具有成本效果的概率为81.5%,但在20万美元阈值下降至14.7%。
  • 每年输卵管切除术较输精管切除术减少1,215例意外妊娠、6,085例卵巢癌病例和4,921例卵巢癌死亡。

核心结论

  • 在10万美元/QALY支付意愿阈值下,输卵管切除术与输精管切除术相比不具有成本效果,尽管意外妊娠率和卵巢癌社会负担更低。
  • 作者认为共享决策、包括讨论输卵管切除术的长期健康获益,对于决定永久避孕方式的夫妇很重要。

研究设计与样本

  • 决策树模型研究,使用TreeAge评估输精管切除术与输卵管切除术用于永久避孕的成本效果。
  • 假定队列为800,000人,即美国每年接受永久避孕操作的男性和女性患者数。
  • 效果以质量调整生命年(QALY)表示,支付意愿阈值设为每获得或损失一个QALY 100,000美元。
  • 成本和概率从文献中获取,估计两种策略间的增量成本效果比(ICER)。
  • 完成10,000次模拟的概率敏感性分析,并绘制支付意愿阈值从0至200,000美元的成本效果可接受曲线。

主要发现

  • 输卵管切除术不具有成本效果,与输精管切除术相比的ICER为每QALY 143,769美元。
  • 概率敏感性分析显示输精管切除术具有成本效果的概率为81.5%,但在200,000美元支付意愿阈值下降至14.7%。
  • 每年输卵管切除术与输精管切除术相比减少1,215例意外妊娠、6,085例卵巢癌病例和4,921例卵巢癌死亡。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the cost effectiveness of salpingectomy compared with vasectomy for couples seeking permanent contraception. METHODS: We developed a decision tree model that used TreeAge to evaluate the cost effectiveness of vasectomy compared with salpingectomy for a hypothetical cohort of 800,000 people, the number of male and female patients who undergo permanent contraception procedures in the United States annually. Effectiveness was expressed in quality-adjusted life-years (QALYs), and the willingness-to-pay (WTP) threshold was set to $100,000 per QALY gained or lost. We derived costs, probabilities, and utilities from the literature, and estimated the incremental cost-effectiveness ratio (ICER) between the two strategies. We completed a probabilistic sensitivity analysis with 10,000 simulations and created a cost-effectiveness acceptability curve for WTP thresholds from $0 to $200,000. Secondary outcomes included the number of unintended pregnancies, ovarian cancer cases, and ovarian cancer deaths. RESULTS: Salpingectomy was not a cost-effective strategy, with an ICER of $143,769 per QALY gained compared with vasectomy. Probabilistic sensitivity analysis showed that the chance of vasectomy being cost effective was 81.5% but decreased to 14.7% with a WTP threshold of $200,000. Annually, salpingectomy was associated with 1,215 fewer unintended pregnancies, 6,085 fewer ovarian cancer cases, and 4,921 fewer ovarian cancer deaths compared with vasectomy. CONCLUSION: Salpingectomy is not cost effective compared with vasectomy at a WTP threshold of $100,000, despite lower unintended pregnancy rates and societal ovarian cancer burden. Shared decision making, including a discussion of the long-term health benefits of salpingectomy, is important for couples deciding on permanent contraception procedures.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Pearson A, Shvartsman K, Zeng W, et al. Cost Effectiveness of Salpingectomy Compared With Vasectomy for Permanent Contraception. Obstet Gynecol. 2025. PMID: 40875993. doi:10.1097/AOG.0000000000006042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。